These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 37932113)

  • 21. Bacteriophage-antibiotic combination therapy against extensively drug-resistant Pseudomonas aeruginosa infection to allow liver transplantation in a toddler.
    Van Nieuwenhuyse B; Van der Linden D; Chatzis O; Lood C; Wagemans J; Lavigne R; Schroven K; Paeshuyse J; de Magnée C; Sokal E; Stéphenne X; Scheers I; Rodriguez-Villalobos H; Djebara S; Merabishvili M; Soentjens P; Pirnay JP
    Nat Commun; 2022 Sep; 13(1):5725. PubMed ID: 36175406
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Host and pathogen response to bacteriophage engineered against Mycobacterium abscessus lung infection.
    Nick JA; Dedrick RM; Gray AL; Vladar EK; Smith BE; Freeman KG; Malcolm KC; Epperson LE; Hasan NA; Hendrix J; Callahan K; Walton K; Vestal B; Wheeler E; Rysavy NM; Poch K; Caceres S; Lovell VK; Hisert KB; de Moura VC; Chatterjee D; De P; Weakly N; Martiniano SL; Lynch DA; Daley CL; Strong M; Jia F; Hatfull GF; Davidson RM
    Cell; 2022 May; 185(11):1860-1874.e12. PubMed ID: 35568033
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Phage Therapy in the Resistance Era: Where Do We Stand and Where Are We Going?
    Luong T; Salabarria AC; Roach DR
    Clin Ther; 2020 Sep; 42(9):1659-1680. PubMed ID: 32883528
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Isolation of antibiotic-resistant gram-negative organisms from donor respiratory culture does not impact non-lung solid organ recipient management.
    Benamu E; Pereira MR; Taimur S; Jacobs SE; Friedman AL; Jenkins SG; Herold BC; Pellett Madan R
    Clin Transplant; 2019 Aug; 33(8):e13646. PubMed ID: 31230392
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Past and Future of Phage Therapy and Phage-Derived Proteins in Patients with Bone and Joint Infection.
    Ferry T; Kolenda C; Briot T; Souche A; Lustig S; Josse J; Batailler C; Pirot F; Medina M; Leboucher G; Laurent F; On Behalf Of The Lyon Bji Study Group ; On Behalf Of The PHAGEinLYON Study Group
    Viruses; 2021 Dec; 13(12):. PubMed ID: 34960683
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bacteriophages and phage-delivered CRISPR-Cas system as antibacterial therapy.
    Yeh TK; Jean SS; Lee YL; Lu MC; Ko WC; Lin HJ; Liu PY; Hsueh PR
    Int J Antimicrob Agents; 2022 Jan; 59(1):106475. PubMed ID: 34767917
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical Phage Microbiology: a suggested framework and recommendations for the in-vitro matching steps of phage therapy.
    Gelman D; Yerushalmy O; Alkalay-Oren S; Rakov C; Ben-Porat S; Khalifa L; Adler K; Abdalrhman M; Coppenhagen-Glazer S; Aslam S; Schooley RT; Nir-Paz R; Hazan R
    Lancet Microbe; 2021 Oct; 2(10):e555-e563. PubMed ID: 35544180
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Isolation of Phage Lysins That Effectively Kill Pseudomonas aeruginosa in Mouse Models of Lung and Skin Infection.
    Raz A; Serrano A; Hernandez A; Euler CW; Fischetti VA
    Antimicrob Agents Chemother; 2019 Jul; 63(7):. PubMed ID: 31010858
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Multidrug-Resistant and Extended-Spectrum β-Lactamase Gram-Negative Bacteria in Bilateral Lung Transplant Recipients: Incidence, Risk Factors, and In-Hospital Mortality.
    Boscolo A; Sella N; Pettenuzzo T; De Cassai A; Crociani S; Schiavolin C; Simoni C; Geraldini F; Lorenzoni G; Faccioli E; Fortarezza F; Lunardi F; Giraudo C; Dell'Amore A; Cattelan A; Calabrese F; Gregori D; Rea F; Navalesi P
    Chest; 2022 Dec; 162(6):1255-1264. PubMed ID: 35850288
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Multidrug-resistant Gram-negative bacterial infections in solid organ transplant recipients-Guidelines from the American Society of Transplantation Infectious Diseases Community of Practice.
    Pouch SM; Patel G;
    Clin Transplant; 2019 Sep; 33(9):e13594. PubMed ID: 31102483
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Stability Considerations for Bacteriophages in Liquid Formulations Designed for Nebulization.
    Flint R; Laucirica DR; Chan HK; Chang BJ; Stick SM; Kicic A
    Cells; 2023 Aug; 12(16):. PubMed ID: 37626867
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bacteriophage therapy against Pseudomonas aeruginosa biofilms: a review.
    Chegini Z; Khoshbayan A; Taati Moghadam M; Farahani I; Jazireian P; Shariati A
    Ann Clin Microbiol Antimicrob; 2020 Sep; 19(1):45. PubMed ID: 32998720
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bacteriophage therapy against ESKAPE bacterial pathogens: Current status, strategies, challenges, and future scope.
    Kulshrestha M; Tiwari M; Tiwari V
    Microb Pathog; 2024 Jan; 186():106467. PubMed ID: 38036110
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Proof-of-Principle Study in a Murine Lung Infection Model of Antipseudomonal Activity of Phage PEV20 in a Dry-Powder Formulation.
    Chang RYK; Chen K; Wang J; Wallin M; Britton W; Morales S; Kutter E; Li J; Chan HK
    Antimicrob Agents Chemother; 2018 Feb; 62(2):. PubMed ID: 29158280
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Multidrug-resistant bacterial infections after liver transplantation: an ever-growing challenge.
    Santoro-Lopes G; de Gouvêa EF
    World J Gastroenterol; 2014 May; 20(20):6201-10. PubMed ID: 24876740
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Phage therapy for respiratory infections.
    Chang RYK; Wallin M; Lin Y; Leung SSY; Wang H; Morales S; Chan HK
    Adv Drug Deliv Rev; 2018 Aug; 133():76-86. PubMed ID: 30096336
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Phage therapy as strategy to face post-antibiotic era: a guide to beginners and experts.
    Royer S; Morais AP; da Fonseca Batistão DW
    Arch Microbiol; 2021 May; 203(4):1271-1279. PubMed ID: 33474609
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A Systematic and Critical Review of Bacteriophage Therapy Against Multidrug-resistant ESKAPE Organisms in Humans.
    El Haddad L; Harb CP; Gebara MA; Stibich MA; Chemaly RF
    Clin Infect Dis; 2019 Jun; 69(1):167-178. PubMed ID: 30395179
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Standard technical specifications for methacholine chloride (Methacholine) bronchial challenge test (2023)].
    ; ;
    Zhonghua Jie He He Hu Xi Za Zhi; 2024 Feb; 47(2):101-119. PubMed ID: 38309959
    [TBL] [Abstract][Full Text] [Related]  

  • 40. What's Old Is New Again: Bacteriophage Therapy in the 21st Century.
    Aslam S; Schooley RT
    Antimicrob Agents Chemother; 2019 Dec; 64(1):. PubMed ID: 31685458
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.